DANAGA TRAINING AND CONSULTING, LLC – Trademark Portfolio
Entity Type: 16
DANAGA TRAINING AND CONSULTING, LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 32 (Light Beverages) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include CHICPILL and CHICSHOT. The owner is based in HOUSTON, TX.
1258 CHIMNEY ROCK RD.
HOUSTON, TX 77056
Showing of trademarks Trademarks
Trademark Classifications
DANAGA TRAINING AND CONSULTING, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages
Frequently Asked Questions
How many trademarks does DANAGA TRAINING AND CONSULTING, LLC have?
DANAGA TRAINING AND CONSULTING, LLC has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 cancelled.
What trademark classes does DANAGA TRAINING AND CONSULTING, LLC file in?
DANAGA TRAINING AND CONSULTING, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 32 (Light Beverages). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are DANAGA TRAINING AND CONSULTING, LLC's most well-known trademarks?
DANAGA TRAINING AND CONSULTING, LLC's registered trademark portfolio includes well-known marks such as CHICPILL and CHICSHOT. These are among 2 currently registered trademarks in the portfolio.
What is DANAGA TRAINING AND CONSULTING, LLC's trademark registration success rate?
DANAGA TRAINING AND CONSULTING, LLC has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.